daewon pharmaceutical co ltd
(003220:Korea Stock Exchange (Koscom))

Last 11,850 KRW

Change Today +350.00 / 3.04%

Volume 86.3K

003220 On Other Exchanges

Symbol

Exchange

003220:KS

As of 2:24 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

daewon pharmaceutical co ltd (003220) Snapshot

Open 11,500		Previous Close 11,500
Day High 11,900		Day Low 11,300
52 Week High 04/5/13 - 13,800		52 Week Low 06/4/12 - 4,223
Market Cap 184.7B		Average Volume 10 Days 117.2K
EPS TTM 622.73		Shares Outstanding 15.6M
EX-Date 12/27/12		P/E TM 19.0x
Dividend 45.45		Dividend Yield 0.38%

Current Stock Chart for DAEWON PHARMACEUTICAL CO LTD (003220)

003220:KS Historical Stock Quote
003220:KS Advanced Stock Chart

Related News

No related news articles were found.

daewon pharmaceutical co ltd (003220) Related Businessweek News

No Related Businessweek News Found

daewon pharmaceutical co ltd (003220) Details

Daewon Pharm. Co. Ltd., a pharmaceutical company, engages in the manufacture and sale of medicines in South Korea and internationally. The company primarily offers vitamins and health foods; and medicines for circulatory, respiratory, antibiotic, mental neurological, chemotherapy, and psychoneurosis uses, as well as antipyretic, analgesic, antiinflammatory, gastrointestinal, antimicrobial, cardiovascular, metabolic, neuromuscular, endocrine, and other drugs. Its principal products include Oramin-F soft cap., a multivitamin; Pelubi tablet for pain relief; Aquafol inj. for the anti-exogenous infectious bacteria; Megex-I susp., a medicine supplementing subalimentation of cancer patients; Trigel susp./tab. for the therapy of gastritis and duodenal ulcer; and Metran cap. for use in mammalian physiology. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Detailed 003220:KS Company Description...

www.daewonpharm.com

Founded in 1958

daewon pharmaceutical co ltd (003220) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

daewon pharmaceutical co ltd (003220) Key Developments

Daewon Pharmaceutical Co. Ltd., Annual General Meeting, Mar 15, 2013

Feb 25 13

Daewon Pharmaceutical Co. Ltd., Annual General Meeting, Mar 15, 2013., at 10:00 Korea Standard Time. Location: Hyangnam factory Large Conference Room. Agenda: To approve the audit report, sales report, senior external auditor reporting and the consolidated financial statements; to approve statement of appropriation of retained earnings and dividend; to consider the directors' remuneration limit; and to consider the other references useful for making investment decisions.

Daewon Pharmaceutical Co. Ltd., Annual General Meeting, Mar 16, 2012

Mar 13 12

Daewon Pharmaceutical Co. Ltd., Annual General Meeting, Mar 16, 2012.